Company
Tarsus Pharmaceuticals, Inc. (TARS)
Standardized SEC financial data for Tarsus Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001819790 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-15.7%
Net margin
-14.7%
Revenue growth (YoY)
146.7%
Return on equity
-19.3%
ROIC
-24.1%
Free cash flow
-$22.3M
Debt / equity
0.21×
Current ratio
3.85×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $57.0M | $25.8M | $17.4M | $183.0M | $451.4M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $168.1M | $171.3M | $71.7M | $224.9M | $97.4M | $186.2M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$21.1M | $3.7M | -$49.0M | -$117.5M | -$83.0M | -$12.5M |
| Capital expenditures |
Get TARS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TARS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TARS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"